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Abstract
This work presents a study of film coating with the vaginal strain 
of Lactobacillus acidophilus, the aim of which was to dry the 
bacteria and manufacture probiotic tablets in one step and to 
enhance the survival rate of bacteria and their viability during 
storage. The results show that the film coated lactose-based tab-
lets contained viable bacteria and the survival rate after the pro-
cess was 21 %, which could be enhanced up to 59 % by applying 
protective media (trehalose, sucrose, reconstituted skim milk 
(RSM)) during dehydration. Additionally, protective agents 
improved the viability of bacteria during storage too. After one 
year, 20 % of the embedded bacteria were active when stored 
at –20°C, and viability dropped only one order of magnitude 
when stored at 7°C. It was verified that the bacteria in film 
coated tablets were not sensitive to higher levels of humidity 
owing to the moisture-moderating polyvinyl alcohol-based 
coating composite. The described technology for production 
of tablets containing living bacteria by tablet coating seems 
industrially feasible as tablet film coaters are widespread in the 
pharmaceutical industry.
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1 Introduction
The consumption of probiotic products is expected to 
increase in following years owing to the wide range of posi-
tive effects associated with their application [1]. To guarantee 
the long term stability of probiotics, it is necessary to develop 
an optimal method for the dehydration of the probiotic suspen-
sion. Although the solidification of probiotic microorganisms 
can be considered to be widespread, there is still challenge 
in it because different kinds of stress (e.g. osmotic, thermal, 
mechanical etc.) can damage the cells during their conventional 
manufacturing [2]. Our aim was to develop an industrially 
feasible alternative way of solid formulation of bioproducts 
through the example of Lactobacillus acidophilus (LBA). This 
type of  bacteria is one of the most widely investigated and 
applied species, especially in the field of dairy industry, and 
it is an important part of normal human bacterial flora located 
usually in mouth, in the gastrointestinal tract and in the urinary 
and genital tracts of females [3, 4]. Bacterial vaginosis (BV) is 
a common infection caused by an imbalance of normal vaginal 
micro flora. This is in connection with the deficiency of Lacto-
bacillus bacteria, which are replaced by undesirable exogenous 
microorganisms [5]. The treatment of this infection is a major 
challenge for healthcare as about one third of women are con-
cerned (29 % in the United States [6]). Normally, a large number 
of Lactobacillus bacteria are present in vaginal microbiota that 
prevent the colonization and proliferation of pathogenic micro-
organisms through several ways, such as competition for nutri-
ents and adherence, production of H2O2 [7], bacteriocins [8] and 
lactic acid (which is mainly responsible for the protective acidic 
pH of the vagina [9]). During BV the vaginal pH rises above 4.5 
accompanied by the almost total disappearance of Lactobacillus 
bacteria [10]. The efficacy of standard antibiotic treatments has 
decreased (because of the spread of resistant bacteria strains and 
increasing refusal of antibiotics by the patients). Therefore, new, 
effective, readily accessible and economical lactobacilli-based 
probiotic therapies are badly needed. Intra-vaginal administra-
tion of Lactobacillus acidophilus has a better capability to cure 
BV compared to reference treatments, such as metronidazole 
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tablet, estrogen cream, acetic acid jelly and tampon containing 
acetic acid or placebo [11, 12, 13]. Furthermore, a recent review 
drew attention to the increased importance of probiotic treat-
ment for prevention of BV, stating that more serious complica-
tions can be avoided this way [14].
Beside the emerging alternative technologies (e.g. electro-
spinning [15]), currently the most widely applied drying tech-
nology for solidification of fermented bacterial suspensions is 
freeze drying, because it takes place at low temperature, thus 
avoiding heat degradation. However, freeze drying also causes 
losses in cell viability through damaging of cell membranes by 
ice crystals. Uzunova-Doneva et al. showed that particularly 
the rate of freezing can determine the loss of viability of bacte-
ria [16]. Furthermore, S. Rudy and C. Ratti pointed out another 
very important disadvantage of freeze drying, namely that it is 
time-consuming and has high energy demand [17, 18].
Another widespread drying technology is spray drying, 
where dry powder is made from suspensions by atomizing it 
in hot drying air. Temperature of inlet air is usually between 
100 and 200°C, which can cause serious heat damage in cells 
by degradation of ribosomes and other cellular structures [19]. 
Riveros et al. and Wang et al. spray dried Lactobacillus acido-
philus under gentle conditions (inlet temperature: 100°C, out-
let temperature: 58°C, 60°C). Nevertheless, survival rates were 
only 11 % and 4.9 % respectively [20, 21]. 
After the drying process, it is necessary to create a suitable 
formulation of dried bacteria. Tablets can provide easy adminis-
tration, long-term stability and optimize the adhesion and colo-
nization of bacteria to the epithelial mucosa by using appropri-
ate excipients (e.g. lactose as nutrient for bacteria, polyvinyl 
pyrrolidone, polyvinyl alcohol as gelling agent etc.) [22].
The tablet dosage form has other advantages as well, such 
as good patient compliance, precise dosage, feasible large-scale 
production [23]. However, during tablet formulation the high 
compression force can cause a significant loss of viability due to 
mechanical damage of the bacteria [24], which means an addi-
tional decrease in activity. According to E. S. Chan et. al. [25], 
upper punch pressure between 90 and 180 MPa causes 20 % and 
60 % loss in the viability of bacteria. Further detrimental effect 
can be caused by the increased temperature induced by friction 
during tablet pressing. This increase in temperature is generally 
between 5 and 70°C and hot spots of 100°C are discussed [26, 
27]. It means that bacteria potentially have to face temperatures 
over 60°C, which is very harmful to the biomolecules (ribo-
somes, proteins, cell membrane lipids, DNA) of the bacteria 
and can cause considerable loss of cell viability [28].
It would be advantageous to manufacture tablets containing 
bacteria in a way that allows avoiding these harmful effects. 
Film coating of lactose-based (nutrition for LBA) tablets with 
bacteria-containing coating solutions can be a proper way to 
produce stable formulations with high bacteria content and at 
the same time avoid compression and attendant loss of viability. 
Film coating is one of the oldest pharmaceutical processes, 
generally applied to protect the API, enhance mechanical integ-
rity and modify release profile. Currently, the most commonly 
used coating device is the side-vented perforated pan coater, 
which enables very efficient drying and allows short coating 
times. Nowadays, more than 90 % of tablets are film coated, 
and it can be achievable even as a continuous process, so it is 
an efficient and economical alternative of the currently known 
methods [29]. The aim of this work was to develop a method to 
produce lactose-based tablets with high bacteria content from 
fermented Lactobacillus acidophilus, avoiding the time- and 
energy-consuming freeze drying and the harmful tablet com-
pression. We intended to investigate the possibility of solid for-
mulation of LBA using film coating technology and the effect 
of different stabilizers on long term stability.
2 Materials
The model biodrug Lactobacillus acidophilus (Strain 
number: B1075) was kindly provided by National Collec-
tion of Agricultural and Industrial Microrganisms (Budapest, 
Hungary). The strain was stored at 7°C in MRS Agar (de 
Man, Rogosa and Sharpe Agar, LabM, UK). Placebo tablet 
cores were made from a-lactose monohydrate (Tablettose 
80, Meggle, Germany), colloid silicon dioxide (Aerosil 200, 
Evonik, Germany), magnesium stearate (Parchem, USA) and 
microcrystalline cellulose (Vivapur 102 (particle size: 100µm), 
JRS Pharma, Germany). Tablets were coated by Opadry II clear 
(Colorcon, UK), PVA based water soluble coating. During fer-
mentation and viability tests bacteria were cultured in MRS 
Broth and MRS Agar. Stabilizers were trehalose, reconstituted 
skimmed milk (RSM) and sucrose (Merck, Germany).
3 Methods
3.1 Tablet compression
The easy-to-apply oblong-shaped placebo tablets were com-
pressed with Korsch (Germany) single punch tablet press from 
the mixture of a-lactose monohydrate (Tablettose 80) (79.2 
m/m%) as diluent and nutrient for bacteria, colloid silicium 
dioxide (Aerosil 200) (0.4 %) as glidant, magnesium stearate 
(0.4 %) as lubricant and microcrystalline cellulose (Vivapur 
102, particle size: 100µm) (20 %) as binder. The mass of tablets 
was 1 g, the length, height and thickness of them were 19 mm, 
9 mm and 6 mm respectively.
3. 2 Preparing bacteria suspension
Lactobacillus acidophilus was stored at 7°C on MRS Agar 
for long term storage. Three E-flask cultures of MRS broth 
were inoculated with LBA harvested from MRS Agar. Before 
the inoculation MRS Broth was freshly prepared and sterilized. 
According to the instructions of the manufacturer 55 g of MRS 
Broth powder was added to 1 l of deionized water and after 
total dissolution it was autoclaved at 121°C for 30 minutes in 
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the E-flasks. The fermentation was performed at 37°C. After 
48h of fermentation, bacterial cells was harvested and centri-
fuged for 3 minutes with Heraeus Labofuge 400 R (Germany). 
Rotational speed was 4200 rpm.
3.3 Freeze drying
According to Zayed et. al. [30], sucrose (4 m/m%), trehalose 
(4 m/m%) and RSM (modified to 8 m/m% in order to prepare 
homogeneous film-coating suspension) were added to the centri-
fuged bacteria suspension (32 g) as stabilizers [31, 32]. After total 
dissolution aliquots in sterile glass vials was frozen at –20°C in a 
deep freezer for 2 h, and then desiccated under vacuum (2 mbar) 
at –3°C in the freeze-drier (Christ alpha 1–4, Germany) for 24 h. 
Three independent freeze drying processes were performed.
3.4 Film coating
The film coating was performed using a laboratory scale 
tablet coating machine (Glatt GC 250, Switzerland) equipped 
with a perforated rotating drum and Schlick bifluid spraying 
gun. 40 g of PVA-based Opadry II clear coating material was 
suspended in 200 ml of dist. water by stirring (500 rpm). After 
45 minutes the bacterial suspension was added to the coating 
suspension. The mass of bacterial suspension was 32 g without 
stabilizers and 38 g when it contained sucrose (4 m/m%), tre-
halose (4 m/m%) and RSM (8 m/m%). The coating drum was 
filled with 800 g of lactose-based tablets and preheated with 
warm air (inlet air temperature was 45°C). The amount of the 
consumed coating suspension was measured with a balance and 
it was sprayed at a speed of 9 g/min. The coating machine was 
equipped with one sprayer. The applied spraying pressure was 
2.7 bar and the rotational speed of the drum was 20 rpm. Three 
independent film coating process were performed. Hardness of 
20 coated and uncoated tablets was measured with a Schleuni-
ger 4M hardness tester (Switzerland). Thickness of coating was 
measured on ten tablets by using the software of SEM.
3.5 Scanning electron microscopy (SEM)
Morphology of the film-coated tablets was investigated by 
a JEOL 6380LVa (JEOL, Japan) type scanning electron micro-
scope. Each specimen was fixed by conductive double sided 
carbon adhesive tape and sputtered by gold (using JEOL 1200 
instrument) in order to avoid electrostatic charging. Applied 
voltage was 15 kV. SEM image of suspension was taken of cen-
trifuged bacteria suspension slushed onto the sample holder.
3.6 Viability test
In order to determine the number of colony forming units 
in the prepared freeze dried powder and in the tablets their 
weighted pieces (or one tablet in the case of tablets) were dis-
solved completely using 9 ml of sterilized water (stock solu-
tion). Hereinafter these initial solutions were diluted in nine 
steps (1 step = 10-fold dilution) and after each step 1 ml of 
solution was pipetted onto an MRS agar plate. Agar plates were 
kept in a lockup plastic box containing activated Microbiology 
Anaerocult® (Merck, Germany), which provided anaerobic 
circumstances by adsorbing oxygen. These were held at 37°C 
for 48 hours then the formed colonies were enumerated (colony 
forming unit = CFU) and the viability was calculated. All the 
viability results presented in this paper are the mean values of 
three independent replicate assays. The relative standard devia-
tions of these measurements were below 5 %.
3.7 Storage test
Samples containing LBA were kept in lockup containers 
at different temperatures (room temperature, 7°C and –20°C, 
which correspond to the temperatures of a freezer and a fridge 
respectively) in order to model everyday storage conditions. 
Furthermore, the effect of moisture content on the activity of 
bacteria was examined at 7°C. One desiccator contained P2O5 
(Merck, Germany), ensuring 0 % relative humidity. A second 
one contained saturated aqueous NaCl (Merck, Germany) solu-
tion, providing 75 % relative humidity. Viability of LBA bacteria 
in the samples was monitored in the storage period and CFU/g 
was determined. The applied method to determine cell viability 
was the plating procedure described in the Viability test part.
3.8 Dissolution test
In order to determine the release time of living LBA from 
film coated tablets, they were dissolved in 10 ml of dist. water. 
Dissolution vessels were shaken with a speed of 50 rpm, tem-
perature of dissolution media was 25°C. After 1, 2, 3, 5, 10 and 
20 minutes 1 ml of the dissolution medium was diluted in eight 
steps (1 step = 10-fold dilution) and after each step 1 ml pipet-
ted to MRS agar plate and the dissolution media was refilled 
with dist. water. The method of plating procedure was the same 
that was described above in this article. Dissolution was calcu-
lated as follows: the CFU number at different time points was 
divided by the total CFU number at the end of the dissolution 
test, which was considered as 100 %.
4 Results and discussion
The following results of formulation experiments served the 
evaluation of the performance of film coating technology in 
comparison with the conventional freeze drying process. Con-
cerning the preparation of solid formulations containing bac-
teria, film coating is similar to spray drying; however, it pro-
vides much more gentle circumstances owing to lower drying 
temperature. Therefore film coating is suitable for the effec-
tive manufacturing of tablets containing bacteria even at large 
scale, owing to the easy scalability of the technology.
The first coating experiments served for optimizing the pro-
cess parameters and providing reference tablets for the investi-
gation of the effect of stabilizers (these were carried out with-
out any stabilizer).
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4.1 Film coating
During film coating process 800 g placebo tablets were 
coated with polymer suspension containing bacteria. During 
the process average mass gain of tablets was around 4 % and 
around 5 % when the coating solution contained stabilizers. In 
each case three independent coating processes were performed.
The viscosity of the coating solution did not change signifi-
cantly after the bacteria suspension had been added. Therefore, 
there was no need to increase the water content of the coating 
solution. During the coating process the outlet temperature did 
not exceed 38°C; thus, the thermal damage of bacteria could 
be avoided. After the coating process, defects (e.g. twinning, 
capping, sticking, etc.) were not observed. Mechanical strength 
of uncoated tablets was 250 N and it was 161 N after the coat-
ing. This reduction was caused by the increased water content 
of tablet core, but it still means a good mechanical strength. 
After one year the average hardness of coated tablets was 155 
N which means that the coated tablets have preserved their 
mechanical stability. Before the coating relative standard devi-
ation of mass of tablet cores was 0.58 % and it was 0.79 % after 
the coating which meant that the film coating suspension was 
homogeneously distributed on the tablet cores.
Scanning electron microscopic studies were performed on the 
coated tablets to examine the coating layer containing LBA and 
the distribution of the bacteria in it. As illustrated by Fig. 1a, 
LBA loaded coating has continuous and uniform appearance (the 
damage under the coating originates from sample preparation).
The thickness of the formed film was about 140 ± 10 µm. 
The SEM image with higher magnification reveals the bacteria 
in the coating layer (Fig. 1a). Their average sizes inside the film 
are similar to that of their original form (width: ~0.5–0.7 μm; 
length: ~1–3 μm) shown in Fig. 1c.
Table 1 shows the drying results of the film coating given 
as the average of three independent experiments. The coating 
suspension (272 g) contained 6.16x108 CFU. Since 40 g of the 
coating material was suspended in the solvent the CFU number 
related to dry matter content was 4.19x106 CFU/mg. Average 
mass gain of tablets was 39 mg; thus, the theoretical maximum 
of bacteria content in tablets was 39x4.19x106=1.63x108. This 
calculation does not take into account the dry matter content 
of bacteria that would reduce the theoretical maximum of CFU 
and, simultaneously increase the survival rates presented in fol-
lowings. Average bacteria content of tablets was 3.51x107 after 
the process, which means nearly 80 % loss in the activity of 
bacteria relative to the theoretical maximum of bacteria content. 
This deactivation could only be caused by dehydration damage 
as heat damage was avoided during film coating by applying 
relatively low process temperature (38°C), which is very gentle 
compared to spray drying [33]. During dehydration the removal 
of water results in an increase in the transition temperature asso-
ciated with the liquid crystal to gel transition (Tm, melting tem-
perature) and causes detrimental effect on viability after rehy-
dration, due to the potential leakage of cell membrane [34].
Some compounds such as trehalose, sucrose and reconsti-
tuted skimmed milk (RSM) can act as protective agents during 
drying, which were supposed to stabilize the cellular structures 
or act as a kind of physical shield moderating the heat and 
osmotic stresses [35].
Fig. 1 Scanning electron micrographs of placebo tablets coated with LBA loaded coating polymer (a: cross-section , b: surface) and the suspension of LBA with 
thickness and length data (c)
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Film coating was repeated using these protective carriers. 
In this case, the theoretical maximum of CFU in tablets was 
5.91x107 because average mass gain of tablets was 50 mg. After 
the film coating one tablet contained 3.50x107 active bacteria 
which means that the survival rate of bacteria after coating was 
tripled (Table 1) by applying protective agents. Nearly 60 % 
of theoretical maximum were still active after drying, which 
means great progress compared to spray drying.
In order to give a proper comparison between film coating 
and the most commonly used freeze drying, we investigated 
the effect of circumstances of freeze drying on the viability of 
LBA, applying the same protective carriers (Table 2). Results of 
freeze drying obtained in three independent experiments were 
as follows. The suspension (38 g) contained 1.68x1010 CFU per 
g before freezing. After freeze drying average mass of freeze 
dried powder was 7.46 g and it contained 5.31x107 CFU per mg, 
which means 62 % of initial bacteria survived the dehydration.
These results indicate that if appropriate stabilizers are 
applied, film coating can be a feasible solid formulation method 
of living LBA instead of freeze drying. Advantage of this pro-
cess is the direct formation of administration-ready tablets. In 
contrast, freeze drying results in a powder containing bacteria 
that needs a final formulation step to obtain tablets accompa-
nied with the possibility of viability loss due to mechanical and 
heat stresses. (Freeze dried tablets are also known, but their 
mechanical strength is very low, which makes their application 
unpractical, particularly in the case of BV.)
4.2 Stability of bacteria in the solid dosage form
It is well known that the drying technology has important 
effects not only on the viability of the solid bacteria but also on 
the long-term stability of them [32]. The change in the bacte-
ria content in film coated tablets prepared without stabilizers 
is shown in Fig. 2. Survival rate of bacteria during the storage 
period was significantly a function of storage temperature. Room 
temperature had a huge detrimental effect; after 6 months there 
were no active bacteria alive in the product, which was predict-
able because marketed biopharmaceutical products containing 
living organism have to be stored generally at 2-8°C. The curves 
of tablets stored at 7 and –20°C are parallel and after one year 
they contained huge amount of active bacteria but the survival 
rate was still quite low, only 0.32 % and 3.96 % respectively.
Fig. 2 Viability of bacteria in film coated tablets without stabilizers
Figure 3 shows the significantly improved stability of for-
mulations in presence of stabilizers. Survival rate of bacteria 
after one year could be increased this way remarkably not only 
at 7°C (2.78 %) and –20°C (19.44 %), but also at ambient 
temperature.
Table 1 Average results of film coating processes
Film coating Film coating with stabilizers
Coating suspension CFU/g 6.16x108 1.96x108
CFU number refers to 1 mg of dry 
matter content of coating suspension
4.19x106 1.18x106
Mass gain per tablet (mg) 39 50
Theoretical maximum of CFU/tablet 1.63x108 5.91x107
CFU/tablet 3.51x107 3.50x107
Survival rate 21% (RSD: 10.0%) 59% (RSD: 5.9%) 
Table 2 Results of freeze drying obtained in three independent experiments
Initial suspension CFU/g 1.68x1010
Average mass of freeze dried powder 7.46 g
CFU number refers to 1mg of dry matter content of initial 
suspension
8.56x107
Number of CFU in 1 mg of freeze dried powder 5.31x107
Survival rate 62 % (RSD: 3.7%) 
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These remarkable results mean great progress compared to 
the stability of freeze dried bacteria. As it can be seen in Fig. 
4, despite of protective agents (sucrose, trehalose and reconsti-
tuted skimmed milk (RSM) the survival rate after a year was 
only 1 % and 0.08 % in the case of frozen (–20°C) and chilled 
(7°C) lyophilizates, and after six months all of the bacteria lost 
their activity at ambient temperature.
These results confirm the advantages of the film coating pro-
cess in the formulation of probiotics. As it was described earlier 
this way of formulation provides less harsh conditions resulting 
in higher survival rate compared to spray drying [20, 21], fur-
thermore, stability results showed that the produced tablets pre-
served higher rate of living bacteria than the freeze dried products 
after one year, owing to the relatively gentle conditions applied 
during coating and protective effect of the coating polymer.
4.3 Effect of humidity on dried bacteria
Another important factor of stability during storage is the 
moisture content. The results showed that desiccation of the 
freeze dried powder with 0 % moisture content was required to 
achieve a positive effect on viability (1.67x106 CFU/mg after 12 
weeks), while the 75 % moisture level was detrimental (4.25x105 
CFU/mg after 12 weeks) (Fig. 5). In contrast to this, not even 
a higher level of humidity caused significant decreasing in the 
case of tablets (Fig. 6), which is most likely a result of the PVA-
based coating composite, which created a moisture moderating 
layer on the surface of the tablets. This means that bacteria for-
mulated this way are more resistant to higher humidity and do 
not need special packaging and treatment.
4.4 Dissolution test
After disintegration the lactose content of the tablets acts as 
good nutrient for bacteria, so the prepared formulation could 
combine the advantages of pre- and probiotic pharmaceuticals 
during administration. Immediate release is very important 
for adequate efficiency; therefore, the release time of bacteria 
from the tablet was investigated. According to Fig. 7, the total 
amount of bacteria was released from the tablet within ten min-
utes, which, together with the lactose content of the tablets, can 
ensure a rapid proliferation immediately after administration.
5 Conclusions
Film coating performed with Lactobacillus acidophilus 
resulted in tablets containing living bacteria in one step. The 
survival rate of bacteria after the process was 21 %, but it could 
be enhanced to 59 % by applying protective agents, which 
means great progress compared to spray drying. Furthermore, 
this result indicates that if appropriate stabilizers are applied, 
Fig. 3 Viability of bacteria in film coated tablets with stabilizers Fig. 5 Viability of freeze dried LBA with stabilizers during storage for 12 
weeks at 7°C at different level of humidity
Fig. 4 Viability of freeze dried LBA during storage for 12 months in protec-
tive media at different temperatures
Fig. 6 Viability of LBA with stabilizers in film coating during storage for 12 
weeks at 7°C at different level of humidity
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film coating can be an alternative solid formulation method for 
LBA instead of freeze drying (62 %), which could be more 
efficient, particularly if we take into consideration that after 
film coating there is no need further detrimental formulation 
steps. Stability results showed that the produced tablets con-
tained higher amounts of living bacteria after one year than the 
freeze dried products, owing to the relatively gentle conditions 
applied during coating and the protective effect of the coating 
polymer, which has most likely an important role in the preven-
tion of the detrimental effect of humidity by creating a mois-
ture-moderating layer on the surface of the tablets. Embedded 
bacteria could be released immediately from the thin coating 
layer of the tablets containing lactose nutrient, which can pro-
mote rapid proliferation. This gentle drying technology can be 
applied for not only bacteria but other sensitive APIs for exam-
ple herbal extracts [36, 37].
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